DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-334 Cr | ₹-414 Cr | ₹-283 Cr | ₹136 Cr | ₹-139 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR LAL PATHLABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-334 Cr |
| Mar2024 | ₹-414 Cr |
| Mar2023 | ₹-283 Cr |
| Mar2022 | ₹136 Cr |
| Mar2021 | ₹-139 Cr |
How is Cash Flow from Financing Activities of DR LAL PATHLABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-334 Cr | Negative | |
| Mar2024 | ₹-414 Cr | Negative | |
| Mar2023 | ₹-283 Cr | Negative | |
| Mar2022 | ₹136 Cr | Positive | |
| Mar2021 | ₹-139 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹23,081.9 Cr | 1.3% | -4.6% | 14.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹112,144.0 Cr | 1.7% | 9% | 25.7% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹101,484.0 Cr | -1% | 0.3% | 5.2% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹66,523.1 Cr | -3.2% | 2.9% | 37.2% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,763.1 Cr | 0.6% | 2% | 13% | Stock Analytics | |
| GLOBAL HEALTH | ₹29,736.3 Cr | -0.4% | -3.1% | -9.9% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 1.3% |
-4.6% |
14.3% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses